Evidence map›Paper›PMID 36548780›Full record

ArticleToxins2022

Putative C

Liuke Liang, Haojie Yang, Shan Wei, Shuaibing Zhang, Liang Chen, Yuansen Hu, Yangyong Lv

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liuke LiangCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Haojie YangCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Shan WeiCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Shuaibing ZhangCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Liang ChenCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.ORCID 0000-0002-2357-0925
Yuansen HuCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.
Yangyong LvCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.ORCID 0000-0001-5342-0656
Henan University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aflatoxin is a carcinogenic secondary metabolite that poses a serious threat to human and animal health. Some C

Indexed as

AflatoxinsAflatoxin B1AnimalsAspergillus flavusFungal ProteinsHumansTranscription FactorsVirulenceAflatoxin B1AflatoxinsFungal ProteinsTranscription FactorsaflatoxinAflZKS3Aspergillus flavusC2H2 transcription factorpathogenicity

Identifiers

PMID36548780
PMCPMC9786134
OpenAlexW4312211755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.